Prabda Praphasiri

Nakhon Phanom, 48000, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Influenza Vaccine Effectiveness Against Pneumonia and COPD Exacerbations Among Patients with Chronic Obstructive Pulmonary Disease in Thailand: A National Test-Negative Design Study, 2013-2024.

Influenza Vaccine Effectiveness Against Pneumonia and COPD Exacerbations Among Patients with Chronic Obstructive Pulmonary Disease in Thailand: A National Test-Negative Design Study, 2013-2024.

Journal: Vaccines

Published: July 13, 2026

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

Journal: Vaccines

Published: June 25, 2026

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

Journal: Vaccines

Published: April 28, 2026

Risk of hospitalization related to influenza A(H3N2) virus subclade K, Thailand, June-December 2025.

Risk of hospitalization related to influenza A(H3N2) virus subclade K, Thailand, June-December 2025.

Journal: The Journal of infectious diseases

Published: April 19, 2026

Estimating the National Disease Burden and Economic Burden of Respiratory Syncytial Virus (RSV) in Thailand.

Estimating the National Disease Burden and Economic Burden of Respiratory Syncytial Virus (RSV) in Thailand.

Journal: Influenza and other respiratory viruses

Published: December 18, 2025

Validity of influenza vaccine effectiveness calculations using a test negative design in Thailand.

Validity of influenza vaccine effectiveness calculations using a test negative design in Thailand.

Journal: American journal of epidemiology

Published: August 13, 2025

Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand.

Validity of influenza vaccine effectiveness calculations using a test-negative design in Thailand.

Journal: American journal of epidemiology

Published: August 13, 2025

Influenza surveillance and vaccine policy in Thailand-a historical perspective.

Influenza surveillance and vaccine policy in Thailand-a historical perspective.

Journal: The Lancet regional health. Southeast Asia

Published: June 13, 2025

COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024.

COVID-19 vaccine acceptance and recommendation among health workers in nine countries: a pooled analysis of survey data from 2023 to 2024.

Journal: BMJ global health

Published: May 20, 2025

Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study.

Effectiveness of the 2023 Southern Hemisphere Influenza Vaccine Against Outpatient Influenza-Like Illness: A Multi-Country Test-Negative Design Study.

Journal: Open forum infectious diseases

Published: April 15, 2025

Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.

Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.

Journal: PloS one

Published: December 19, 2024

Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design.

Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design.

Journal: The Lancet. Global health

Published: May 30, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026